Allergan Breast Implant Lawsuit in South Dakota

Time limits apply in South Dakota. Find out if you still qualify.

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Researched By
People's Justice Research Team

Verified against court records, regulatory records, and peer-reviewed research.

Last reviewed: June 11, 2026How we research

Last reviewed against primary sources: June 11, 2026

Statute of Limitations

South Dakota: 3 years from discovery (SDCL § 15-2-14)

3 years from BIA-ALCL diagnosis or discovery of BIOCELL connection

Filing Venue

Where to File in South Dakota

South Dakota has a 3-year personal injury statute under SDCL § 15-2-14 applying from the date of discovery. South Dakota plaintiffs file in MDL 2921 in the District of New Jersey. Sioux Falls plastic surgery practices placed Allergan BIOCELL products during the 2005–2019 period. South Dakota's 3-year window means BIA-ALCL diagnoses from 2023 onward are within the limitations period for South Dakota claimants.

South Dakota Data

Exposure in South Dakota

Source: FDA MAUDE Adverse Event Database

Source: Allergan/AbbVie; FDA Safety Communication